FDA Inspection 694671 — Carter BloodCare

Carter BloodCare — FEI 3000717800

The FDA completed an inspection of Carter BloodCare on October 15, 2010 in Flower Mound, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 15, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Flower Mound, TX (United States)

Citations

IDCFRDescription
6721 CFR 606.65(e)Following manufacturer's instructions
928821 CFR 640.21(a)Eligibility of platelet donors
9821 CFR 606.100(c)Thorough investigations